Novel signal amplification methodology for conventional immunodiagnostic assays. Enables researchers to enhance detection sensitivity without requiring new specialized instrumentation or system changes.
Manufactured by
Cavidi AB
Sweden
Cavidi is the company behind Exazym®, which solves a critical research challenge: ultra-sensitive detection of low-abundance biomarkers using standard immunoassay workflows. It enables biomarker detection by amplifying immunoassay signals up to 100x with minimal background noise, allowing researchers in academic labs, biotech companies, CROs, and hospitals to detect biomarkers previously thought impossible to measure—cardiac troponins, Alzheimer's biomarkers, cytokines—without specialized equipment.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
YASEE BioMedical Inc.
China · 1 relevant product
Axxin
Australia · 4 relevant products
BLINK AG
Germany · 3 relevant products
36 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 51 closest product alternatives
YASEE BioMedical Inc. · China
Advanced diagnostic system utilizing molecular biology techniques for infectious disease and genetic testing. Supports laboratory analysis with high sensitivity and specificity.
Axxin · Australia
Laboratory-grade real-time isothermal amplification platform featuring 3-channel fluorescence and 16-tube format. Provides high-throughput and high-sensitivity capability for advanced molecular diagnostics.
BLINK AG · Germany
A bioanalytical platform solution utilizing magnetic fluorescence encoded nanoreactors technology for diagnostic test development. The platform accelerates the creation of new diagnostic tests and enables broad test offerings for multiple analytes and disease conditions.
48 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products